Namibia - Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q4

Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q4 in Namibia was reported at 5 % in 2013, according to the World Bank collection of development indicators, compiled from officially recognized sources.



Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
 namibia anti malarial drug use by pregnant women sp fansidar two or more doses percent of women with a birth q4 wb data


Anti-malarial drug use by pregnant women: Percentage of women with a live birth in the two years preceding the survey who during the pregnancy took any antimalarial drug for prevention, and who took SP/Fansidar two or more doses.


Namibia | Health







Related

Latest